Thrombosis
Conditions
Brief summary
Study on Management Thrombosis in Greek cancer patients
Detailed description
The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.
Interventions
None listed
Sponsors
Hellenic Society of Medical Oncology
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline. * Age ≥ 18 years * Signed informed consent
Exclusion criteria
* Initiation of anticoagulation therapy before the initiation of the study in 2016 * Age \<18 years * No signed informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The clinical practice for patients under anticoagulation regime | 1 YEAR | Documentation of the clinical practice for patients under anticoagulation regime, for prophylaxis or treatment, in patients with solid tumors, for one year following the protocol initiation date, including high-risk patients as defined in the protocol. |
Countries
Greece
Outcome results
None listed